A unique society dedicated to advancing vision care and improving patients' quality of life through Innovation, Education and Advocacy.

who is AECOS?

AECOS is a truly progressive organization that fosters communication and cooperation between leading anterior segment surgeons, ophthalmic industry executives, select venture capitalists, and technology entrepreneurs. Originally established in 2011 as a congress of American thought leaders, the Society expanded in 2012 to become The American-European Congress of Ophthalmic Surgery®. In 2013, the Society formalized its expansion by creating an American Executive Committee and a European Executive Committee – each chartered to drive the mission and vision of AECOS. Today, this prestigious Society remains dedicated to advancing vision care and improving patients' quality of life through Innovation, Education and Advocacy.

As a non-profit 501(c)(6) ophthalmic Society, AECOS in its first year initiated sponsorship of an important FDA investigational study focused on corneal cross-linking. AECOS also participated with industry and CMS in the development of guidance on Laser Refractive Cataract Surgery.  These guidelines that were published by the Centers for Medicare and Medicaid Services in November 2012. As a Society, AECOS is an advocate for quality patient care, and serves as an active member of the FDA/CDRH Network of Experts.

AECOS is a member of the American Refractive Surgery Council, an organization that harnesses the country's leading clinical and technology expertise and develops educational and informative programs and content for consumers considering their vision correction options.

what makes AECOS different?

“ACOS represents an unprecedented combination of physician and industry leaders working together to benefit our specialty and ultimately our patients. Our mission is tightly focused, and while we don't aspire to have thousands of members, ACOS encompasses a significant percentage of the thought leaders and innovators in ophthalmology.”
Steven J Dell, MD
Austin, Texas

“What makes ACOS unique is we bring together physician and non-physician innovators as peers in a highly interactive, productive forum. This assures we can deliver on our commitment to fostering innovation in ophthalmology . . . for the benefit of the patient and the surgeon.“
William J Link, PhD, Managing Director
Versant Ventures, Newport Beach, California

“I come to AAO to teach; I go to ACOS to learn.”
John A. Hovanesian MD
Laguna Hills, California

"In my 3 years of ophthalmology, I have found the ACOS meetings to be the most valuable I have attended.  As a CEO, the insight gained during these meetings is simply unmatched in our industry and always a must on my calendar."
John Kilcoyne, President and CEO
Revision Optics, Lake Forest, California

"The combination of industry leaders and medical experts meeting together offers a unique atmosphere of work; a symbiosis to build the future of innovations and to design promising medical, social and economical perspectives in ophthalmology”
Béatrice Cochener MD
Brest, France

“ACOS provides a unique vehicle for collaboration among leading surgeons, scientists and industry which is ideal for fostering innovation in anterior segment surgery.”
Michael C Knorz MD
Mannheim, Germany

“ACOS is dedicated to serving the professionals who shape our profession. By bringing together innovators and industry leaders, ACOS creates an environment that validates new ideas and challenges conventional thinking.” 
John A. Vukich MD
Madison, Wisconsin

“As in most of medicine, our field is excelled by innovation and technology development. ACOS combines presentations and debate among many outstanding innovating surgeons along with recognized industry executives, offering a unique forum.”
A.J. Kanellopoulos MD
Athens, Greece

“As a society, ACOS is leading the way in ophthalmic innovation initiatives, bringing together the best and brightest from industry and anterior segment surgery.  Actively participating in ACOS is one of the single most effective ways that the new vanguard of ophthalmology can help shape the future of our specialty, which is not only a pleasure, but a responsibility."  
George O. Waring IV MD, FACS

“ACOS meetings have been fantastic!  ACOS meetings allow for a unique venue where a mix of both physician and industry leaders in ophthalmology present the most cutting edge technology in an interactive format that is rewarding to all who attend.”
William F Wiley, MD
Brecksville, Ohio

“Ophthalmic treatment modalities increase in numbers and diversity for the sake of our patients. ACOS offers a unique, open-minded, excellent meeting platform for all, clinicians, companies as well as investors, to share and discuss new options or diversifications and, therefore, advance patient care.”
H Burkhard Dick MD
Bochum, Germany

“Ophthalmology is a technology-driven specialty and I know of no better meeting place for industry, clinicians and venture capitalists to come together than the ACOS series of meetings. This is where ideas are born, discussed and dissected in an open and transparent forum. Undoubtedly one of my favourite meetings of the year.”
Arthur B Cummings MD


Board of Directors

  • John A. Vukich, MD - Chairman
  • Burkhard Dick, MD
  • David Cox
  • Arthur Cummings, MD
  • Steven J. Dell, MD
  • John F. Doane, MD
  • Adam Krafczek, Esq
  • William Link, PhD
  • Erik Mertens, MD
  • Stephen G. Slade, MD
  • William Trattler, MD
Trudy Larkins - Executive Director

upcoming meetings

AECOS Winter Symposium
Feb 25 - 28, 2018 | St. Regis, Aspen, CO

AECOS European Symposium
May 31 - June 3, 2018 | Berlin, Germany

AECOS Summer Symposium
July 12 - 15, 2018 | St. Regis Hotel, Deer Valley, UT

the corneal cross linking initiative

Principal Investigators in the AECOS Corneal Cross-Linking Study